NewcelX (NCEL) vs Neuphoria Therapeutics (NEUP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Neuphoria Therapeutics (NEUP) has outperformed NewcelX (NCEL) over the past year, losing 81.8% versus a loss of 83.4%. Neuphoria Therapeutics is the larger company by market cap ($18.5 million vs $17.5 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NCEL | NEUP |
|---|---|---|
| Share price | $3.04 | $3.42 |
| Market cap | $17.53M | $18.51M |
| 1-day change | +2.51% | -0.29% |
| YTD return | +59.74% | -11.86% |
| 1-year return | -83.42% | -81.78% |
| 5-year return | -99.69% | — |
| P/E ratio (TTM) | 5.84 | — |
| EPS (TTM) | $0.52 | $-3.06 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $19.07 | $19.21 |
| 52-week low | $1.83 | $3.19 |
| Distance from 52-week high | -84.08% | -82.20% |
| Average volume | 12.22K | 162.11K |
| Shares outstanding | 5.78M | 5.41M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
NCEL vs NEUP FAQ
Which is bigger, NewcelX or Neuphoria Therapeutics?
Neuphoria Therapeutics (NEUP) is larger, with a market capitalization of $18.51M compared with $17.53M for NewcelX (NCEL).
Which stock has performed better over the past year, NCEL or NEUP?
NEUP returned -81.78% over the past 12 months, compared with -83.42% for NCEL (price return, excluding dividends). Past performance does not predict future results.
Are NewcelX and Neuphoria Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.